Form 4: United Therapeutics Director Ray Kurzweil Executes Stock Option and Sells Shares

Director Ray Kurzweil exercised stock options and sold shares of United Therapeutics Corp on February 28, 2025.

Summary

• On February 28, 2025, Ray Kurzweil, a director of United Therapeutics Corporation, exercised stock options to acquire 15,000 shares of common stock at a price of $175.43 per share.
• Following the exercise of the options, Kurzweil sold a total of 15,000 shares in multiple transactions at prices ranging from $314.254 to $323.532 per share.
• After these transactions, Kurzweil directly owns 12,080 shares of United Therapeutics Corp.
• The sales were executed in multiple trades at weighted average prices, and detailed price information is available upon request to the SEC, the issuer, or a security holder.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These filings are monitored by investors to gain insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in beneficial ownership.
• The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates